Professor & patients' paper on the solvable biological challenge of ME/CFS: reader-friendly version
Simon McGrath provides a patient-friendly version of a peer-reviewed paper which highlights some of the most promising biomedical research on ME/CFS ...
Discuss the article on the Forums.

ATA188, Which Kills B-Cells Targeting Epstein-Barr Virus, Shows Promise as MS Treatment

Discussion in 'Other Health News and Research' started by Webdog, May 2, 2017.

  1. Webdog

    Webdog Senior Member

    Very small Phase 1 trial of targeted B-cell therapy for multiple sclerosis patients. Perhaps those more knowledgeable could chime in on whether ME/CFS patients might one day benefit from some kind of targeted B-cell therapy.
    Atara Bio's press release:
    http://investors.atarabio.com/releasedetail.cfm?ReleaseID=1022221
     
    Gemini, Skippa, adelheid55 and 4 others like this.

See more popular forum discussions.

Share This Page